SLC5A2 and Insulin resistance: The precise mechanism by which an SGLT2 inhibitor normalizes disrupted circadian rhythms of BP and SNA is not clear; however, multiple processes may be involved, including reduction of blood glucose level and body weight, improvement of insulin resistance, and initiation of natriuresis (8, 56–60) (Figure 3).